bioAffinity Technologies, Inc.: 10-Q filed 2025-08-14
What bioAffinity Technologies, Inc. reported in its quarterly report filed 2025-08-14 (fiscal Q2 2025): 47 published measures, 132 facts as tagged in accession 0001641172-25-024163.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2025-08-14
- Fiscal period
- fiscal Q2 2025
- Accession
- 0001641172-25-024163 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All bioAffinity Technologies, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 4,751,075 | USD | |
| At 2024-12-31 | 6,513,667 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 6,887,183 | USD | |
| At 2024-12-31 | 3,911,631 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | -2,136,108 | USD | |
| At 2025-03-31 | 1,439,404 | USD | |
| At 2024-12-31 | 2,602,036 | USD | |
| At 2024-06-30 | 3,433,114 | USD | |
| At 2024-03-31 | 5,257,051 | USD | |
| At 2023-12-31 | 4,855,255 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 802,835 | USD | |
| At 2024-12-31 | 1,105,291 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | -4,060,787 | USD | 91 |
| 2025-01-01 to 2025-06-30 | -6,721,204 | USD | 181 |
| 2024-04-01 to 2024-06-30 | -2,110,279 | USD | 91 |
| 2024-01-01 to 2024-06-30 | -4,072,094 | USD | 182 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-06-30 | -4,288,981 | USD | 181 |
| 2024-01-01 to 2024-06-30 | -3,878,400 | USD | 182 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-06-30 | 64,213 | USD | 181 |
| 2024-01-01 to 2024-06-30 | 69,672 | USD | 182 |
Contract revenue excluding tax
Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | 1,269,483 | USD | 91 |
| 2025-01-01 to 2025-06-30 | 3,123,080 | USD | 181 |
| 2024-04-01 to 2024-06-30 | 2,397,652 | USD | 91 |
| 2024-01-01 to 2024-06-30 | 4,804,043 | USD | 182 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-06-30 | 4,050,738 | USD | 181 |
| 2024-01-01 to 2024-06-30 | 1,927,813 | USD | 182 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-06-30 | -64,213 | USD | 181 |
| 2024-01-01 to 2024-06-30 | -69,672 | USD | 182 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | -60,365,514 | USD | |
| At 2024-12-31 | -53,644,310 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | 24,021,546 | shares | 91 |
| 2025-01-01 to 2025-06-30 | 20,148,211 | shares | 181 |
| 2024-04-01 to 2024-06-30 | 11,389,308 | shares | 91 |
| 2024-01-01 to 2024-06-30 | 10,655,483 | shares | 182 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | 24,021,546 | shares | 91 |
| 2025-01-01 to 2025-06-30 | 20,148,211 | shares | 181 |
| 2024-04-01 to 2024-06-30 | 11,389,308 | shares | 91 |
| 2024-01-01 to 2024-06-30 | 10,655,483 | shares | 182 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | -0.17 | USD/shares | 91 |
| 2025-01-01 to 2025-06-30 | -0.2 | USD/shares | 181 |
| 2024-04-01 to 2024-06-30 | -0.19 | USD/shares | 91 |
| 2024-01-01 to 2024-06-30 | -0.38 | USD/shares | 182 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | -0.17 | USD/shares | 91 |
| 2025-01-01 to 2025-06-30 | -0.2 | USD/shares | 181 |
| 2024-04-01 to 2024-06-30 | -0.19 | USD/shares | 91 |
| 2024-01-01 to 2024-06-30 | -0.38 | USD/shares | 182 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | 28,984 | USD | 91 |
| 2025-01-01 to 2025-06-30 | 37,679 | USD | 181 |
| 2024-04-01 to 2024-06-30 | 5,419 | USD | 91 |
| 2024-01-01 to 2024-06-30 | 9,091 | USD | 182 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 351,368 | USD | |
| At 2024-12-31 | 375,385 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-06-30 | 538,223 | USD | 181 |
| 2024-01-01 to 2024-06-30 | 569,907 | USD | 182 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | -2,515,560 | USD | 91 |
| 2025-01-01 to 2025-06-30 | -5,142,699 | USD | 181 |
| 2024-04-01 to 2024-06-30 | -2,087,798 | USD | 91 |
| 2024-01-01 to 2024-06-30 | -4,033,028 | USD | 182 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 1,668,826 | USD | |
| At 2024-12-31 | 2,695,098 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 2,588,304 | USD | |
| At 2024-12-31 | 3,104,905 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 1,169,837 | USD | |
| At 2024-12-31 | 987,311 | USD |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 1,404,486 | USD | |
| At 2024-12-31 | 1,404,486 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | 3,785,043 | USD | 91 |
| 2025-01-01 to 2025-06-30 | 8,265,779 | USD | 181 |
| 2024-04-01 to 2024-06-30 | 4,485,450 | USD | 91 |
| 2024-01-01 to 2024-06-30 | 8,837,071 | USD | 182 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 43,971 | USD | |
| At 2024-12-31 | 27,608 | USD |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | 2,214,561 | USD | 91 |
| 2025-01-01 to 2025-06-30 | 4,667,110 | USD | 181 |
| 2024-04-01 to 2024-06-30 | 2,472,775 | USD | 91 |
| 2024-01-01 to 2024-06-30 | 4,658,719 | USD | 182 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | 311,372 | USD | 91 |
| 2025-01-01 to 2025-06-30 | 678,758 | USD | 181 |
| 2024-04-01 to 2024-06-30 | 402,433 | USD | 91 |
| 2024-01-01 to 2024-06-30 | 796,072 | USD | 182 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 28,459,541 | shares | |
| At 2024-12-31 | 15,576,674 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 58,032,170 | USD | |
| At 2024-12-31 | 56,139,753 | USD |
Operating lease right-of-use asset
Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 399,879 | USD | |
| At 2024-12-31 | 463,011 | USD |
Operating lease liability
Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 407,313 | USD | |
| At 2024-12-31 | 469,596 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 975,849 | USD | |
| At 2024-12-31 | 911,636 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 624,481 | USD | |
| At 2024-12-31 | 536,251 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 745,972 | USD | |
| At 2024-12-31 | 775,139 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 12,814 | USD | |
| At 2024-12-31 | 19,676 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 1,048,034 | USD | |
| At 2024-12-31 | 1,398,722 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 400,151 | USD | |
| At 2024-12-31 | 422,995 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | -4,031,803 | USD | 91 |
| 2025-01-01 to 2025-06-30 | -6,683,525 | USD | 181 |
| 2024-04-01 to 2024-06-30 | -2,104,860 | USD | 91 |
| 2024-01-01 to 2024-06-30 | -4,063,003 | USD | 182 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | 44,468 | USD | 91 |
| 2025-01-01 to 2025-06-30 | 88,231 | USD | 181 |
| 2024-04-01 to 2024-06-30 | 40,243 | USD | 91 |
| 2024-01-01 to 2024-06-30 | 79,054 | USD | 182 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | 14,583 | USD | 91 |
| 2025-01-01 to 2025-06-30 | 29,167 | USD | 181 |
| 2024-04-01 to 2024-06-30 | 14,583 | USD | 91 |
| 2024-01-01 to 2024-06-30 | 29,167 | USD | 182 |
Nonoperating interest expense
Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | 10,460 | USD | 91 |
| 2025-01-01 to 2025-06-30 | 25,945 | USD | 181 |
| 2024-04-01 to 2024-06-30 | 22,249 | USD | 91 |
| 2024-01-01 to 2024-06-30 | 45,799 | USD | 182 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | -1,516,243 | USD | 91 |
| 2025-01-01 to 2025-06-30 | -1,540,826 | USD | 181 |
| 2024-04-01 to 2024-06-30 | -17,062 | USD | 91 |
| 2024-01-01 to 2024-06-30 | -29,975 | USD | 182 |
Interest paid, net
Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-06-30 | 2,567 | USD | 181 |
| 2024-01-01 to 2024-06-30 | 45,799 | USD | 182 |
Income taxes paid, net
Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-06-30 | 37,679 | USD | 181 |
| 2024-01-01 to 2024-06-30 | 9,091 | USD | 182 |
Operating lease payments
Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | 31,443 | USD | 91 |
| 2025-01-01 to 2025-06-30 | 56,238 | USD | 181 |
| 2024-04-01 to 2024-06-30 | 23,434 | USD | 91 |
| 2024-01-01 to 2024-06-30 | 46,402 | USD | 182 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-06-30 | 16,363 | USD | 181 |
| 2024-01-01 to 2024-06-30 | 11,284 | USD | 182 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-06-30 | 182,526 | USD | 181 |
| 2024-01-01 to 2024-06-30 | 243,313 | USD | 182 |
Inspect the source
- Entity
- bioAffinity Technologies, Inc. / CIK 0001712762
- Captured
- 2026-09-21T17:26:51.140Z
- SEC response SHA-256
fa5285c203869b9319360f2941167a3defa69f4ea9ca028f2147c358ba6a6129
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001712762.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))